Jupiter Asset Management LTD Point Biopharma Global Inc. Transaction History

Jupiter Asset Management LTD

  • $11 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 09, 2023
BUY
$6.67 - $9.71 $1.38 Million - $2.01 Million
207,277 Added 65.43%
524,079 $3.5 Million
Q2 2023

Aug 10, 2023
BUY
$6.86 - $10.86 $1.58 Million - $2.49 Million
229,687 Added 263.66%
316,802 $2.87 Million
Q1 2023

May 10, 2023
BUY
$6.78 - $8.1 $590,639 - $705,631
87,115 New
87,115 $633,000

Others Institutions Holding PNT

# of Institutions
1
Shares Held
20K
Call Options Held
0
Put Options Held
0
View Full List

About POINT Biopharma Global Inc.

PNT Quotes by TradingView
  • Ticker PNT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 104,025,000
  • Description
  • POINT Biopharma Global Inc., a radiopharmaceutical company, focuses on the development and commercialization of radioligands that fight cancer. Its lead product candidates include PNT2002, a prostate-specific membrane antigen (PSMA) targeted radioligand that is in Phase III trial for the treatment of metastatic castration-resistant prostate canc...
More about PNT
Track This Portfolio

Track Jupiter Asset Management LTD Portfolio

Follow Jupiter Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jupiter Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Jupiter Asset Management LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email